Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06539715 · ClinicalTrials.gov registry record · Phase 4
Comparison of Visual Field Assessments Between Three Perimeters
A Phase 4 study, sponsored by Gainesville Eye Associates.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT06539715: Completed Phase 4 study, sponsored by Gainesville Eye Associates.
NCT06539715 is a Phase 4 study that has completed, run by Gainesville Eye Associates. The registered enrollment target is 54 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06539715, a Phase 4 study, has completed, sponsored by Gainesville Eye Associates.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will include MD, PSD, FT, VFI, OCT, and a questionnaire.
Primary Outcome
The total time to complete automated perimetry in both eyes.
Interventions
- DIAGNOSTIC_TEST Visual field assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2024-11-18 |
| Est. Completion | 2025-03-12 |
| Phase | Phase 4 |
What the finished NCT06539715 record still lists
NCT06539715 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Visual field assessment is the first listed.
NCT06539715 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06539715 about?
NCT06539715 is a clinical study titled "Comparison of Visual Field Assessments Between Three Perimeters". A single center, prospective, randomized, comparative study of visual field assessments between the TEMPO, VisuALL, and HFA perimeters. Subjects will be assessed at 1 visit. Clinical evaluations will include MD, PSD, FT, VFI, OCT, and a questionnaire.
What is the current status of trial NCT06539715?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2024-11-18. Estimated completion is 2025-03-12.
What interventions are being tested in trial NCT06539715?
The interventions under investigation include: Visual field assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06539715?
This trial is sponsored by Gainesville Eye Associates, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06539715's enrollment target sits among peer trials
54 1223rd of 2000 higher than 772 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI